Contact

All Stories

  1. Focused Ultrasound for Brain Metastases

    Article • Neuro-Oncology Advances, March 2026, Oxford University Press (OUP)

    Dr Ahmad Ozair

  2. Tucatinib, trastuzumab, and capecitabine with stereotactic radiosurgery in patients with brain metastases from HER-2 positive breast cancer (TUTOR): Study protocol for a multicenter phase 1 clinical trial

    Article • BMC Cancer, December 2025, Springer Science + Business Media

    Dr Ahmad Ozair

  3. Microbubble-enhanced transcranial focused ultrasound with temozolomide for patients with high-grade glioma (BT008NA): a multicentre, open-label, phase 1/2 trial

    Article • The Lancet Oncology, December 2025, Elsevier

    Dr Ahmad Ozair

  4. NCOG-66. ‘Core outcome set’ for leptomeningeal disease (LeptoCOS): a multi-disciplinary, international, consensus effort

    Article • Neuro-Oncology, November 2025, Oxford University Press (OUP)

    Dr Ahmad Ozair

  5. SURG-98. Clinical outcomes, operational metrics, and translational insights derived from trials of MR-guided, transcranial, microbubble-enhanced focused ultrasound for brain tumors: a 2010-2025 evidence analysis

    Article • Neuro-Oncology, November 2025, Oxford University Press (OUP)

    Dr Ahmad Ozair

  6. Author Correction: Stereotactic radiosurgery for patients with brain metastases: current principles, expanding indications and opportunities for multidisciplinary care

    Article • Nature Reviews Clinical Oncology, October 2025, Springer Science + Business Media

    Dr Ahmad Ozair

  7. A nomogram to predict development of brain metastasis in non-small cell lung cancer patients: a retrospective analysis using routinely available medical records

    Article • The Lancet Regional Health - Americas, October 2025, Elsevier

    Dr Ahmad Ozair

  8. Acoustic emissions dose and spatial control of blood-brain barrier opening with focused ultrasound

    Article • Device, October 2025, Elsevier

    Dr Ahmad Ozair

  9. Correction: Shortening antibiotic therapy duration for hospital-acquired bloodstream infections in critically ill patients: a causal inference model from the international EUROBACT-2 database

    Article • Intensive Care Medicine, August 2025, Springer Science + Business Media

    Dr Ahmad Ozair

  10. Data from A Population-Level Real-World Analysis and Single-Center Validation of Melanoma Brain Metastasis Epidemiology following Dual-Agent Immunotherapy

    Article • August 2025, American Association for Cancer Research (AACR)

    Dr Ahmad Ozair

  11. Supplemental Figure 1 from A Population-Level Real-World Analysis and Single-Center Validation of Melanoma Brain Metastasis Epidemiology following Dual-Agent Immunotherapy

    Article • August 2025, American Association for Cancer Research (AACR)

    Dr Ahmad Ozair

  12. Supplemental Figure 2 from A Population-Level Real-World Analysis and Single-Center Validation of Melanoma Brain Metastasis Epidemiology following Dual-Agent Immunotherapy

    Article • August 2025, American Association for Cancer Research (AACR)

    Dr Ahmad Ozair

  13. Supplemental Figure 3 from A Population-Level Real-World Analysis and Single-Center Validation of Melanoma Brain Metastasis Epidemiology following Dual-Agent Immunotherapy

    Article • August 2025, American Association for Cancer Research (AACR)

    Dr Ahmad Ozair

  14. Supplemental Table 1 from A Population-Level Real-World Analysis and Single-Center Validation of Melanoma Brain Metastasis Epidemiology following Dual-Agent Immunotherapy

    Article • August 2025, American Association for Cancer Research (AACR)

    Dr Ahmad Ozair

  15. Supplemental Table 2 from A Population-Level Real-World Analysis and Single-Center Validation of Melanoma Brain Metastasis Epidemiology following Dual-Agent Immunotherapy

    Article • August 2025, American Association for Cancer Research (AACR)

    Dr Ahmad Ozair

  16. Global, Regional, and National Burden of Nontraumatic Subarachnoid Hemorrhage

    Article • JAMA Neurology, August 2025, American Medical Association (AMA)

    Dr Mohammed Kuddus, Professor Yousef Khader, Dr Akshaya Srikanth Bhagavathula, Dr Sonu Bhaskar, Dr Nelsensius Klau Fauk, Dr Ahmad Ozair, Dr Sheikh M Alif, Professor Vijay Kumar Chattu, Dr. Farrokh Habibzadeh, Professor Ovidiu Constantin Baltatu, Professor Tarek Tawfik Amin, Dr. Georgios D Panos, Dr Fakher Rahim, Yihun Miskir

  17. DSAI-08 MACHINE LEARNING-BASED PREDICTION OF INPATIENT CARE COSTS FOR PATIENTS WITH BRAIN METASTASES: A CLAIMS-BASED ANALYSIS

    Article • Neuro-Oncology Advances, August 2025, Oxford University Press (OUP)

    Dr Ahmad Ozair

  18. NCTQ-10 INPATIENT CARE COSTS AND ASSOCIATED REIMBURSEMENTS FOR PATIENTS WITH LEPTOMENINGEAL METASTATIC DISEASE: A REAL-WORLD CLAIMS-BASED ANALYSIS

    Article • Neuro-Oncology Advances, August 2025, Oxford University Press (OUP)

    Dr Ahmad Ozair

  19. RMTD-03 SOCIOECONOMIC DISPARITIES IN CLINICAL TRIAL ENROLLMENT AMONG PATIENTS WITH BRAIN METASTASES: A CENTRAL PENNSYLVANIA CROSS-SECTIONAL ANALYSIS IN NEIGHBORHOOD-DISADVANTAGE METRICS

    Article • Neuro-Oncology Advances, August 2025, Oxford University Press (OUP)

    Dr Ahmad Ozair

  20. RMTD-09 ‘CORE OUTCOME SET’ FOR LEPTOMENINGEAL DISEASE (LEPTOCOS): A MULTI-DISCIPLINARY, INTERNATIONAL, CONSENSUS EFFORT

    Article • Neuro-Oncology Advances, August 2025, Oxford University Press (OUP)

    Dr Ahmad Ozair

  21. RMTD-10 THERAPIES FOR LEPTOMENINGEAL METASTATIC DISEASE: A NETWORK META-ANALYSIS

    Article • Neuro-Oncology Advances, August 2025, Oxford University Press (OUP)

    Dr Ahmad Ozair

  22. RMTD-11 EVALUATING THE QUALITY OF CONDUCT AND REPORTING OF CLINICAL PRACTICE GUIDELINES IN CNS METASTASES

    Article • Neuro-Oncology Advances, August 2025, Oxford University Press (OUP)

    Dr Ahmad Ozair

  23. Survival in Patients with Colorectal Cancer and Isolated Brain Metastases: Temporal Trends and Prognostic Factors from the National Cancer Database (2010–2020)

    Article • Cancers, July 2025, MDPI AG

    Dr Ahmad Ozair

  24. Editorial: Towards 2030: sustainable development goal 3: good health and wellbeing. A sociological perspective

    Article • Frontiers in Sociology, June 2025, Frontiers

    Dr Ahmad Ozair

  25. A population-level real-world analysis and single-center validation of melanoma brain metastasis epidemiology following dual-agent immunotherapy

    Article • Clinical Cancer Research, June 2025, American Association for Cancer Research (AACR)

    Dr Ahmad Ozair

  26. A multicenter, pivotal trial of microbubble-enhanced transcranial focused ultrasound (MB-FUS) for plasma-based liquid biopsy in patients with glioblastoma (LIBERATE).

    Article • Journal of Clinical Oncology, June 2025, American Society of Clinical Oncology (ASCO)

    Dr Ahmad Ozair

  27. A multicenter, randomized, controlled, pivotal trial of microbubble-enhanced transcranial focused ultrasound for patients with NSCLC brain metastases (LIMITLESS).

    Article • Journal of Clinical Oncology, June 2025, American Society of Clinical Oncology (ASCO)

    Dr Ahmad Ozair

  28. Multicenter trial of microbubble-enhanced transcranial focused ultrasound (MB-FUS) with monthly adjuvant temozolomide for patients with high-grade gliomas.

    Article • Journal of Clinical Oncology, June 2025, American Society of Clinical Oncology (ASCO)

    Dr Ahmad Ozair

  29. Association of Health Disparities with Glioblastoma Treatment and Outcomes: Insights from a 15-Year National Cohort (2005–2020)

    Article • Brain Sciences, May 2025, MDPI AG

    Dr Ahmad Ozair

  30. Stereotactic radiosurgery for patients with brain metastases: current principles, expanding indications and opportunities for multidisciplinary care

    Article • Nature Reviews Clinical Oncology, March 2025, Springer Science + Business Media

    Dr Ahmad Ozair

  31. Shortening antibiotic therapy duration for hospital-acquired bloodstream infections in critically ill patients: a causal inference model from the international EUROBACT-2 database

    Article • Intensive Care Medicine, March 2025, Springer Science + Business Media

    Dr Ahmad Ozair

  32. Serum Thyroid-Stimulating Hormone and 25-Hydroxycholecalciferol Levels in Children with Autism Spectrum Disorder and Intellectual Disability in Northern India: A Matched-Case-Control Study

    Article • January 2025, Authorea, Inc.

    Dr Ahmad Ozair

  33. Acoustic Emissions Dose and Spatial Control of Blood-Brain Barrier Opening with Focused Ultrasound

    Article • January 2025, Elsevier

    Dr Ahmad Ozair

  34. Leptomeningeal Disease

    Article • January 2025, Elsevier

    Dr Ahmad Ozair

  35. Leptomeningeal metastatic disease: new frontiers and future directions

    Article • Nature Reviews Clinical Oncology, December 2024, Springer Science + Business Media

    Dr Ahmad Ozair

  36. Burden of disease scenarios by state in the USA, 2022–50: a forecasting analysis for the Global Burden of Disease Study 2021

    Article • The Lancet, December 2024, Elsevier

    Dr Sonu Bhaskar, Dr Ahmad Ozair, Professor Vijay Kumar Chattu, Dr Akshaya Srikanth Bhagavathula, Dr Omotayo Francis Fagbule, Dr. Najim Z. Alshahrani, Asrat Arja Wolde, Oluwaseun Ogundijo, Natália Cruz-Martins, Dr Shrikant Pawar, Dr Ruth W Kimokoti

  37. Effect of adequacy of empirical antibiotic therapy for hospital-acquired bloodstream infections on intensive care unit patient prognosis: a causal inference approach using data from the Eurobact2 study

    Article • Clinical Microbiology and Infection, December 2024, Elsevier

    Dr Ahmad Ozair

  38. Immune checkpoint inhibitors for glioblastoma: emerging science, clinical advances, and future directions

    Article • Journal of Neuro-Oncology, November 2024, Springer Science + Business Media

    Dr Ahmad Ozair

  39. BIOS-01. MACHINE LEARNING-BASED PREDICTION OF INPATIENT CARE COSTS FOR PATIENTS WITH BRAIN METASTASES: A REAL-WORLD ANALYSIS

    Article • Neuro-Oncology, November 2024, Oxford University Press (OUP)

    Dr Ahmad Ozair

  40. BIOS-04. THERAPIES FOR LEPTOMENINGEAL DISEASE: A NETWORK META-ANALYSIS

    Article • Neuro-Oncology, November 2024, Oxford University Press (OUP)

    Dr Ahmad Ozair

  41. CTNI-32. A MULTICENTER PHASE 1 TRIAL OF TUCATINIB, TRASTUZUMAB, AND CAPECITABINE WITH STEREOTACTIC RADIOSURGERY IN PATIENTS WITH BRAIN METASTASES FROM HER2 POSITIVE BREAST CANCER (TUTOR)

    Article • Neuro-Oncology, November 2024, Oxford University Press (OUP)

    Dr Ahmad Ozair

  42. EPID-14. PATTERNS OF CARE AND PROGNOSTIC FACTORS FOR PATIENTS WITH BRAIN METASTASES FROM COLON CANCER: A REAL-WORLD STUDY

    Article • Neuro-Oncology, November 2024, Oxford University Press (OUP)

    Dr Ahmad Ozair

  43. EPID-15. INPATIENT CARE COSTS AND ASSOCIATED REIMBURSEMENTS FOR PATIENTS WITH LEPTOMENINGEAL DISEASE: A REAL-WORLD ANALYSIS

    Article • Neuro-Oncology, November 2024, Oxford University Press (OUP)

    Dr Ahmad Ozair

  44. EPID-17. REAL-WORLD OUTCOMES OF BRAIN METASTASES FROM PANCREATIC CANCER: AN ANALYSIS OF 1266 PATIENTS

    Article • Neuro-Oncology, November 2024, Oxford University Press (OUP)

    Dr Ahmad Ozair

  45. EPID-18. PATTERNS OF CARE AND CLINICAL OUTCOMES OF PATIENTS WITH GLIOBLASTOMA FROM 2005-2020: A REAL-WORLD ANALYSIS

    Article • Neuro-Oncology, November 2024, Oxford University Press (OUP)

    Dr Ahmad Ozair

  46. INNV-15. A PIVOTAL, MULTICENTER TRIAL OF FOCUSED ULTRASOUND FOR BLOOD-BRAIN BARRIER DISRUPTION FOR PLASMA-BASED LIQUID BIOPSY IN PATIENTS WITH GLIOBLASTOMA (LIBERATE)

    Article • Neuro-Oncology, November 2024, Oxford University Press (OUP)

    Dr Ahmad Ozair

  47. RTID-03. A MULTICENTER, RANDOMIZED, CONTROLLED TRIAL OF FOCUSED-ULTRASOUND-MEDIATED BLOOD-BRAIN BARRIER DISRUPTION PLUS SYSTEMIC PEMBROLIZUMAB FOR PATIENTS WITH NSCLC BRAIN METASTASES (LIMITLESS)

    Article • Neuro-Oncology, November 2024, Oxford University Press (OUP)

    Dr Ahmad Ozair

  48. RTID-04. A MULTICENTER, RANDOMIZED, CONTROLLED PHASE 2B TRIAL OF SURVIVIN VACCINE SURVAXM PLUS ADJUVANT TEMOZOLOMIDE FOR NEWLY-DIAGNOSED GLIOBLASTOMA (SURVIVE)

    Article • Neuro-Oncology, November 2024, Oxford University Press (OUP)

    Dr Ahmad Ozair

  49. Peer Review Report For: Development and Initial Implementation of a Clinical Monitoring Strategy in a Non-regulated Trial: a research note from the ReStOre II Trial [version 3; peer review: 3 approved]

    Article • October 2024, Faculty of 1000, Ltd.

    Dr Ahmad Ozair

  50. Advancing spine evidence synthesis: North American Spine Society (NASS) Guidelines

    Article • October 2024, World Evidence-Based Healthcare Day

    Dr Ahmad Ozair

  51. Global, regional, and national burden of stroke and its risk factors, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021

    Article • The Lancet Neurology, October 2024, Elsevier

    Dr Yuan-Pang Wang, Prof. Atanu Biswas, Dr Mohammed Kuddus, Professor Yousef Khader, Sumaira Mubarik, Dr Akram Mahmoud Asbeutah, Assistant Professor Ashok Pandey, Professor Erkin Mirrakhimov, Dr Sonu Bhaskar, Dr Dawit Zemedikun, Mr Nauman Khalid, Dr Ahmad Ozair, Sok King Ong, Mr Auwal Abdullahi, Dr Akshaya Srikanth Bhagavathula, Dr Nelsensius Klau Fauk, Dr Omotayo Francis Fagbule, Dr. Najim Z. Alshahrani, Dr Sheikh M Alif, Professor Vijay Kumar Chattu, Prince Peprah, Dr. Farrokh Habibzadeh, Mesfin Abebe, Professor Muayyad M Ahmad, Professor Ovidiu Constantin Baltatu, Professor Tarek Tawfik Amin, Dr Shankar M Bakkannavar, Dr. Alok Atreya, Jawad Fares, Professor Bruno Ramos Nascimento, Godfrey Rwegerera, Natália Cruz-Martins, Mr. Amadou Barrow, Dr Shrikant Pawar, Dr Fakher Rahim, Dr Ruth W Kimokoti, Professor Catarina Fonseca

  52. P14.02.B A MULTICENTER, RANDOMIZED, CONTROLLED TRIAL OF FOCUSED-ULTRASOUND-MEDIATED BLOOD-BRAIN BARRIER DISRUPTION PLUS SYSTEMIC PEMBROLIZUMAB FOR PATIENTS WITH NSCLC BRAIN METASTASES (LIMITLESS)

    Article • Neuro-Oncology, October 2024, Oxford University Press (OUP)

    Dr Ahmad Ozair

  53. P14.05.A A PROSPECTIVE, MULTICENTER TRIAL OF FOCUSED ULTRASOUND FOR BLOOD-BRAIN BARRIER DISRUPTION FOR LIQUID BIOPSY IN GLIOBLASTOMA (LIBERATE)

    Article • Neuro-Oncology, October 2024, Oxford University Press (OUP)

    Dr Ahmad Ozair

  54. P10.19.A MACHINE LEARNING-BASED PREDICTION OF INPATIENT CARE COSTS FOR PATIENTS WITH BRAIN METASTASES: A REAL-WORLD ANALYSIS

    Article • Neuro-Oncology, October 2024, Oxford University Press (OUP)

    Dr Ahmad Ozair

  55. KS03.4.A PATTERNS OF CARE AND CLINICAL OUTCOMES OF PATIENTS WITH GLIOBLASTOMA IN THE UNITED STATES FROM 2005-2020: A REAL-WORLD ANALYSIS

    Article • Neuro-Oncology, October 2024, Oxford University Press (OUP)

    Dr Ahmad Ozair

  56. P17.15.A PATTERNS OF CARE AND OUTCOMES IN BRAIN METASTASES FROM BILIARY TRACT CANCERS IN THE UNITED STATES: A REAL-WORLD ANALYSIS

    Article • Neuro-Oncology, October 2024, Oxford University Press (OUP)

    Dr Ahmad Ozair

  57. P06.11.A TUTOR: A MULTICENTER, PHASE 1 TRIAL OF TUCATINIB, TRASTUZUMAB, AND CAPECITABINE WITH STEREOTACTIC RADIOSURGERY FOR BRAIN METASTASES FROM HER-2 POSITIVE BREAST CANCER

    Article • Neuro-Oncology, October 2024, Oxford University Press (OUP)

    Dr Ahmad Ozair

  58. Program Signaling and Geographic Preferences in the United States Residency Match for Neurosurgery

    Article • Cureus, September 2024, Springer Science + Business Media

    Dr Ahmad Ozair

  59. 458P Patterns of care and clinical outcomes of patients with glioblastoma in the United States from 2005-2020: A real-world analysis

    Article • Annals of Oncology, September 2024, Elsevier

    Dr Ahmad Ozair

  60. Data from Evaluating the Base Excision Repair Inhibitor TRC102 and Temozolomide for Patients with Recurrent Glioblastoma in the Phase 2 Adult Brain Tumor Consortium Trial BERT

    Article • August 2024, American Association for Cancer Research (AACR)

    Dr Ahmad Ozair

  61. Data from Evaluating the Base Excision Repair Inhibitor TRC102 and Temozolomide for Patients with Recurrent Glioblastoma in the Phase 2 Adult Brain Tumor Consortium Trial BERT

    Article • August 2024, American Association for Cancer Research (AACR)

    Dr Ahmad Ozair

  62. Supplementary Appendix S1 from Evaluating the Base Excision Repair Inhibitor TRC102 and Temozolomide for Patients with Recurrent Glioblastoma in the Phase 2 Adult Brain Tumor Consortium Trial BERT

    Article • August 2024, American Association for Cancer Research (AACR)

    Dr Ahmad Ozair

  63. Supplementary Appendix S1 from Evaluating the Base Excision Repair Inhibitor TRC102 and Temozolomide for Patients with Recurrent Glioblastoma in the Phase 2 Adult Brain Tumor Consortium Trial BERT

    Article • August 2024, American Association for Cancer Research (AACR)

    Dr Ahmad Ozair

  64. Supplementary Figure S1 from Evaluating the Base Excision Repair Inhibitor TRC102 and Temozolomide for Patients with Recurrent Glioblastoma in the Phase 2 Adult Brain Tumor Consortium Trial BERT

    Article • August 2024, American Association for Cancer Research (AACR)

    Dr Ahmad Ozair

  65. Supplementary Figure S1 from Evaluating the Base Excision Repair Inhibitor TRC102 and Temozolomide for Patients with Recurrent Glioblastoma in the Phase 2 Adult Brain Tumor Consortium Trial BERT

    Article • August 2024, American Association for Cancer Research (AACR)

    Dr Ahmad Ozair

  66. Supplementary Figure S2 from Evaluating the Base Excision Repair Inhibitor TRC102 and Temozolomide for Patients with Recurrent Glioblastoma in the Phase 2 Adult Brain Tumor Consortium Trial BERT

    Article • August 2024, American Association for Cancer Research (AACR)

    Dr Ahmad Ozair

  67. Supplementary Figure S2 from Evaluating the Base Excision Repair Inhibitor TRC102 and Temozolomide for Patients with Recurrent Glioblastoma in the Phase 2 Adult Brain Tumor Consortium Trial BERT

    Article • August 2024, American Association for Cancer Research (AACR)

    Dr Ahmad Ozair

  68. Supplementary Figure S3 from Evaluating the Base Excision Repair Inhibitor TRC102 and Temozolomide for Patients with Recurrent Glioblastoma in the Phase 2 Adult Brain Tumor Consortium Trial BERT

    Article • August 2024, American Association for Cancer Research (AACR)

    Dr Ahmad Ozair

  69. Supplementary Figure S3 from Evaluating the Base Excision Repair Inhibitor TRC102 and Temozolomide for Patients with Recurrent Glioblastoma in the Phase 2 Adult Brain Tumor Consortium Trial BERT

    Article • August 2024, American Association for Cancer Research (AACR)

    Dr Ahmad Ozair

  70. Supplementary Figure S4 from Evaluating the Base Excision Repair Inhibitor TRC102 and Temozolomide for Patients with Recurrent Glioblastoma in the Phase 2 Adult Brain Tumor Consortium Trial BERT

    Article • August 2024, American Association for Cancer Research (AACR)

    Dr Ahmad Ozair

  71. Supplementary Figure S4 from Evaluating the Base Excision Repair Inhibitor TRC102 and Temozolomide for Patients with Recurrent Glioblastoma in the Phase 2 Adult Brain Tumor Consortium Trial BERT

    Article • August 2024, American Association for Cancer Research (AACR)

    Dr Ahmad Ozair

  72. Supplementary Figure S5 from Evaluating the Base Excision Repair Inhibitor TRC102 and Temozolomide for Patients with Recurrent Glioblastoma in the Phase 2 Adult Brain Tumor Consortium Trial BERT

    Article • August 2024, American Association for Cancer Research (AACR)

    Dr Ahmad Ozair

  73. Supplementary Figure S5 from Evaluating the Base Excision Repair Inhibitor TRC102 and Temozolomide for Patients with Recurrent Glioblastoma in the Phase 2 Adult Brain Tumor Consortium Trial BERT

    Article • August 2024, American Association for Cancer Research (AACR)

    Dr Ahmad Ozair

  74. Supplementary Figure S6 from Evaluating the Base Excision Repair Inhibitor TRC102 and Temozolomide for Patients with Recurrent Glioblastoma in the Phase 2 Adult Brain Tumor Consortium Trial BERT

    Article • August 2024, American Association for Cancer Research (AACR)

    Dr Ahmad Ozair

  75. Supplementary Figure S6 from Evaluating the Base Excision Repair Inhibitor TRC102 and Temozolomide for Patients with Recurrent Glioblastoma in the Phase 2 Adult Brain Tumor Consortium Trial BERT

    Article • August 2024, American Association for Cancer Research (AACR)

    Dr Ahmad Ozair

  76. Supplementary Figure S7 from Evaluating the Base Excision Repair Inhibitor TRC102 and Temozolomide for Patients with Recurrent Glioblastoma in the Phase 2 Adult Brain Tumor Consortium Trial BERT

    Article • August 2024, American Association for Cancer Research (AACR)

    Dr Ahmad Ozair

  77. Supplementary Figure S7 from Evaluating the Base Excision Repair Inhibitor TRC102 and Temozolomide for Patients with Recurrent Glioblastoma in the Phase 2 Adult Brain Tumor Consortium Trial BERT

    Article • August 2024, American Association for Cancer Research (AACR)

    Dr Ahmad Ozair

  78. Supplementary Table S1 from Evaluating the Base Excision Repair Inhibitor TRC102 and Temozolomide for Patients with Recurrent Glioblastoma in the Phase 2 Adult Brain Tumor Consortium Trial BERT

    Article • August 2024, American Association for Cancer Research (AACR)

    Dr Ahmad Ozair

  79. Supplementary Table S1 from Evaluating the Base Excision Repair Inhibitor TRC102 and Temozolomide for Patients with Recurrent Glioblastoma in the Phase 2 Adult Brain Tumor Consortium Trial BERT

    Article • August 2024, American Association for Cancer Research (AACR)

    Dr Ahmad Ozair

  80. Supplementary Table S2 from Evaluating the Base Excision Repair Inhibitor TRC102 and Temozolomide for Patients with Recurrent Glioblastoma in the Phase 2 Adult Brain Tumor Consortium Trial BERT

    Article • August 2024, American Association for Cancer Research (AACR)

    Dr Ahmad Ozair

  81. Supplementary Table S2 from Evaluating the Base Excision Repair Inhibitor TRC102 and Temozolomide for Patients with Recurrent Glioblastoma in the Phase 2 Adult Brain Tumor Consortium Trial BERT

    Article • August 2024, American Association for Cancer Research (AACR)

    Dr Ahmad Ozair

  82. Supplementary Table S3 from Evaluating the Base Excision Repair Inhibitor TRC102 and Temozolomide for Patients with Recurrent Glioblastoma in the Phase 2 Adult Brain Tumor Consortium Trial BERT

    Article • August 2024, American Association for Cancer Research (AACR)

    Dr Ahmad Ozair

  83. Supplementary Table S3 from Evaluating the Base Excision Repair Inhibitor TRC102 and Temozolomide for Patients with Recurrent Glioblastoma in the Phase 2 Adult Brain Tumor Consortium Trial BERT

    Article • August 2024, American Association for Cancer Research (AACR)

    Dr Ahmad Ozair

  84. Data from Evaluating the Base Excision Repair Inhibitor TRC102 and Temozolomide for Patients with Recurrent Glioblastoma in the Phase 2 Adult Brain Tumor Consortium Trial BERT

    Article • August 2024, American Association for Cancer Research (AACR)

    Dr Ahmad Ozair

  85. Supplementary Appendix S1 from Evaluating the Base Excision Repair Inhibitor TRC102 and Temozolomide for Patients with Recurrent Glioblastoma in the Phase 2 Adult Brain Tumor Consortium Trial BERT

    Article • August 2024, American Association for Cancer Research (AACR)

    Dr Ahmad Ozair

  86. Supplementary Appendix S1 from Evaluating the Base Excision Repair Inhibitor TRC102 and Temozolomide for Patients with Recurrent Glioblastoma in the Phase 2 Adult Brain Tumor Consortium Trial BERT

    Article • August 2024, American Association for Cancer Research (AACR)

    Dr Ahmad Ozair

  87. Supplementary Figure S1 from Evaluating the Base Excision Repair Inhibitor TRC102 and Temozolomide for Patients with Recurrent Glioblastoma in the Phase 2 Adult Brain Tumor Consortium Trial BERT

    Article • August 2024, American Association for Cancer Research (AACR)

    Dr Ahmad Ozair

  88. Supplementary Figure S1 from Evaluating the Base Excision Repair Inhibitor TRC102 and Temozolomide for Patients with Recurrent Glioblastoma in the Phase 2 Adult Brain Tumor Consortium Trial BERT

    Article • August 2024, American Association for Cancer Research (AACR)

    Dr Ahmad Ozair

  89. Supplementary Figure S2 from Evaluating the Base Excision Repair Inhibitor TRC102 and Temozolomide for Patients with Recurrent Glioblastoma in the Phase 2 Adult Brain Tumor Consortium Trial BERT

    Article • August 2024, American Association for Cancer Research (AACR)

    Dr Ahmad Ozair

  90. Supplementary Figure S2 from Evaluating the Base Excision Repair Inhibitor TRC102 and Temozolomide for Patients with Recurrent Glioblastoma in the Phase 2 Adult Brain Tumor Consortium Trial BERT

    Article • August 2024, American Association for Cancer Research (AACR)

    Dr Ahmad Ozair

  91. Supplementary Figure S3 from Evaluating the Base Excision Repair Inhibitor TRC102 and Temozolomide for Patients with Recurrent Glioblastoma in the Phase 2 Adult Brain Tumor Consortium Trial BERT

    Article • August 2024, American Association for Cancer Research (AACR)

    Dr Ahmad Ozair

  92. Supplementary Figure S3 from Evaluating the Base Excision Repair Inhibitor TRC102 and Temozolomide for Patients with Recurrent Glioblastoma in the Phase 2 Adult Brain Tumor Consortium Trial BERT

    Article • August 2024, American Association for Cancer Research (AACR)

    Dr Ahmad Ozair

  93. Supplementary Figure S4 from Evaluating the Base Excision Repair Inhibitor TRC102 and Temozolomide for Patients with Recurrent Glioblastoma in the Phase 2 Adult Brain Tumor Consortium Trial BERT

    Article • August 2024, American Association for Cancer Research (AACR)

    Dr Ahmad Ozair

  94. Supplementary Figure S4 from Evaluating the Base Excision Repair Inhibitor TRC102 and Temozolomide for Patients with Recurrent Glioblastoma in the Phase 2 Adult Brain Tumor Consortium Trial BERT

    Article • August 2024, American Association for Cancer Research (AACR)

    Dr Ahmad Ozair

  95. Supplementary Figure S5 from Evaluating the Base Excision Repair Inhibitor TRC102 and Temozolomide for Patients with Recurrent Glioblastoma in the Phase 2 Adult Brain Tumor Consortium Trial BERT

    Article • August 2024, American Association for Cancer Research (AACR)

    Dr Ahmad Ozair

  96. Supplementary Figure S5 from Evaluating the Base Excision Repair Inhibitor TRC102 and Temozolomide for Patients with Recurrent Glioblastoma in the Phase 2 Adult Brain Tumor Consortium Trial BERT

    Article • August 2024, American Association for Cancer Research (AACR)

    Dr Ahmad Ozair

  97. Supplementary Figure S6 from Evaluating the Base Excision Repair Inhibitor TRC102 and Temozolomide for Patients with Recurrent Glioblastoma in the Phase 2 Adult Brain Tumor Consortium Trial BERT

    Article • August 2024, American Association for Cancer Research (AACR)

    Dr Ahmad Ozair

  98. Supplementary Figure S6 from Evaluating the Base Excision Repair Inhibitor TRC102 and Temozolomide for Patients with Recurrent Glioblastoma in the Phase 2 Adult Brain Tumor Consortium Trial BERT

    Article • August 2024, American Association for Cancer Research (AACR)

    Dr Ahmad Ozair

  99. Supplementary Figure S7 from Evaluating the Base Excision Repair Inhibitor TRC102 and Temozolomide for Patients with Recurrent Glioblastoma in the Phase 2 Adult Brain Tumor Consortium Trial BERT

    Article • August 2024, American Association for Cancer Research (AACR)

    Dr Ahmad Ozair

  100. Supplementary Figure S7 from Evaluating the Base Excision Repair Inhibitor TRC102 and Temozolomide for Patients with Recurrent Glioblastoma in the Phase 2 Adult Brain Tumor Consortium Trial BERT

    Article • August 2024, American Association for Cancer Research (AACR)

    Dr Ahmad Ozair

  101. Supplementary Table S1 from Evaluating the Base Excision Repair Inhibitor TRC102 and Temozolomide for Patients with Recurrent Glioblastoma in the Phase 2 Adult Brain Tumor Consortium Trial BERT

    Article • August 2024, American Association for Cancer Research (AACR)

    Dr Ahmad Ozair

  102. Supplementary Table S1 from Evaluating the Base Excision Repair Inhibitor TRC102 and Temozolomide for Patients with Recurrent Glioblastoma in the Phase 2 Adult Brain Tumor Consortium Trial BERT

    Article • August 2024, American Association for Cancer Research (AACR)

    Dr Ahmad Ozair

  103. Supplementary Table S2 from Evaluating the Base Excision Repair Inhibitor TRC102 and Temozolomide for Patients with Recurrent Glioblastoma in the Phase 2 Adult Brain Tumor Consortium Trial BERT

    Article • August 2024, American Association for Cancer Research (AACR)

    Dr Ahmad Ozair

  104. Supplementary Table S2 from Evaluating the Base Excision Repair Inhibitor TRC102 and Temozolomide for Patients with Recurrent Glioblastoma in the Phase 2 Adult Brain Tumor Consortium Trial BERT

    Article • August 2024, American Association for Cancer Research (AACR)

    Dr Ahmad Ozair

  105. Supplementary Table S3 from Evaluating the Base Excision Repair Inhibitor TRC102 and Temozolomide for Patients with Recurrent Glioblastoma in the Phase 2 Adult Brain Tumor Consortium Trial BERT

    Article • August 2024, American Association for Cancer Research (AACR)

    Dr Ahmad Ozair

  106. Supplementary Table S3 from Evaluating the Base Excision Repair Inhibitor TRC102 and Temozolomide for Patients with Recurrent Glioblastoma in the Phase 2 Adult Brain Tumor Consortium Trial BERT

    Article • August 2024, American Association for Cancer Research (AACR)

    Dr Ahmad Ozair

  107. Peer Review Report For: Development and Initial Implementation of a Clinical Monitoring Strategy in a Non-regulated Trial: a research note from the ReStOre II Trial [version 2; peer review: 2 approved, 1 approved with reservations]

    Article • August 2024, Faculty of 1000, Ltd.

    Dr Ahmad Ozair

  108. A multicenter, phase 1, Adult Brain Tumor Consortium trial of oral terameprocol for patients with recurrent high-grade glioma (GATOR)

    Article • Cell Reports Medicine, July 2024, Elsevier

    Dr Ahmad Ozair

  109. Presentation, management, and outcomes of older compared to younger adults with hospital-acquired bloodstream infections in the intensive care unit: a multicenter cohort study

    Article • Infection, June 2024, Springer Science + Business Media

    Dr Ahmad Ozair

  110. Evaluating the Base Excision Repair Inhibitor TRC102 and Temozolomide for patients with Recurrent Glioblastoma in the Phase 2 Adult Brain Tumor Consortium Trial BERT

    Article • Clinical Cancer Research, June 2024, American Association for Cancer Research (AACR)

    Dr Ahmad Ozair

  111. A randomized, controlled, phase 2 trial of nivolumab plus standard-dose or low-dose bevacizumab for recurrent glioblastoma (NAVAL).

    Article • Journal of Clinical Oncology, June 2024, American Society of Clinical Oncology (ASCO)

    Dr Ahmad Ozair

  112. Examining global and gender disparities in high-impact evidence synthesis on lung cancer: A 2000-2024 analysis of Cochrane Library.

    Article • Journal of Clinical Oncology, June 2024, American Society of Clinical Oncology (ASCO)

    Dr Ahmad Ozair

  113. Impact of race and ethnicity on financial toxicity in patients with genitourinary cancers.

    Article • Journal of Clinical Oncology, June 2024, American Society of Clinical Oncology (ASCO)

    Dr Ahmad Ozair

  114. Pulmonary contusion with hemoptysis from lacrosse ball strike: A case report

    Article • Heliyon, June 2024, Elsevier

    Dr Ahmad Ozair

  115. A multicenter phase 1 trial of tucatinib, trastuzumab, and capecitabine with stereotactic radiosurgery in patients with brain metastases from HER-2–positive breast cancer (TUTOR).

    Article • Journal of Clinical Oncology, June 2024, American Society of Clinical Oncology (ASCO)

    Dr Ahmad Ozair

  116. A multicenter, randomized controlled phase 2b trial of survivin vaccine SurVaxM plus adjuvant temozolomide for newly diagnosed glioblastoma (SURVIVE).

    Article • Journal of Clinical Oncology, June 2024, American Society of Clinical Oncology (ASCO)

    Dr Ahmad Ozair

  117. A prospective, multicenter trial of low-intensity focused ultrasound (LIFU) for blood-brain barrier disruption for liquid biopsy in glioblastoma (LIBERATE).

    Article • Journal of Clinical Oncology, June 2024, American Society of Clinical Oncology (ASCO)

    Dr Ahmad Ozair

  118. CSF proteomics for predicting response to treatment in patients with primary and secondary central nervous system lymphoma.

    Article • Journal of Clinical Oncology, June 2024, American Society of Clinical Oncology (ASCO)

    Dr Ahmad Ozair

  119. Development of clinically accessible nomograms to predict risk of brain metastases at baseline and follow-up in patients with non-small cell lung cancer.

    Article • Journal of Clinical Oncology, June 2024, American Society of Clinical Oncology (ASCO)

    Dr Ahmad Ozair

  120. Dual-agent immunotherapy for prevention of melanoma brain metastases: A real-world analysis of 8686 patients.

    Article • Journal of Clinical Oncology, June 2024, American Society of Clinical Oncology (ASCO)

    Dr Ahmad Ozair

  121. Ethnic disparities in biomarker testing of patients with metastatic NSCLC in the United States: A real-world analysis.

    Article • Journal of Clinical Oncology, June 2024, American Society of Clinical Oncology (ASCO)

    Dr Ahmad Ozair

  122. Health state utility assessment for low-grade glioma.

    Article • Journal of Clinical Oncology, June 2024, American Society of Clinical Oncology (ASCO)

    Dr Ahmad Ozair

  123. Socioeconomic disparities in survival outcomes of patients with SCLC with brain metastases: A nationwide analysis.

    Article • Journal of Clinical Oncology, June 2024, American Society of Clinical Oncology (ASCO)

    Dr Ahmad Ozair

  124. Survival outcomes associated with treatment modalities in stage 4 gallbladder neuroendocrine tumors: A nationwide analysis.

    Article • Journal of Clinical Oncology, June 2024, American Society of Clinical Oncology (ASCO)

    Dr Ahmad Ozair

  125. Treatment outcomes of brain metastasis from primary renal cell carcinoma in United States: A National Cancer Database analysis.

    Article • Journal of Clinical Oncology, June 2024, American Society of Clinical Oncology (ASCO)

    Dr Ahmad Ozair

  126. Socioeconomic disparities in survival outcomes of patients with NSCLC with brain metastases: A real-world analysis.

    Article • Journal of Clinical Oncology, June 2024, American Society of Clinical Oncology (ASCO)

    Dr Ahmad Ozair

  127. Burden of disease scenarios for 204 countries

    Article • The Lancet, May 2024, Elsevier

    Oluwaseun Ogundijo, Dr Yuan-Pang Wang, Dr Salah Thabit Al Awaidy, Deborah Aluh, Dr Sonu Bhaskar, Dr Senbagam Duraisamy, Dr Ahmad Ozair, Ts. Dr Adel Al-Gheethi, Dr Mohammad Sami Alwardat, Prof. Muayyad M Ahmad, Dr Amr Hassan, Sumaira Mubarik, Dr Javad Sharifi Rad, Dr Mohammed Kuddus, Dr Ali Fatehizadeh, Professor Erkin Mirrakhimov, Mr Nauman Khalid, Dr Vahid Rashedi, Sok King Ong, Prof. Manpreet Singh Bhatti, PhD. Carla Sofia FARINHA, Turki Alanzi, Mr Auwal Abdullahi, Dr Ibrahim Elsohaby, Dr Akshaya Srikanth Bhagavathula, Dr Mohammad Hosein Amirzade-Iranaq, Dr Nelsensius Klau Fauk, Dr Omotayo Francis Fagbule, Dr Sheikh M Alif, Dr Shariful Islam, Sandra Barteit, Prince Peprah, Dr. Bolajoko O. Olusanya, Kathryn H. Jacobsen, Mesfin Abebe, Professor Muayyad M Ahmad, Professor Ovidiu Constantin Baltatu, Alexander Mathioudakis, Professor Tarek Tawfik Amin, Professor Richard James Maude, Professor Bruno Ramos Nascimento, Dr. Georgios D Panos, Dr. Shu Wang, Natália Cruz-Martins, Dr Shrikant Pawar, Ejemai Eboreime, Dr Fakher Rahim, Dr Ruth W Kimokoti

  128. MP08-17 OUTCOMES OF INVASIVE PRIMARY URETHRAL CANCER IN WOMEN (IPUC): AN ANALYSIS FROM THE NATIONAL CANCER DATABASE

    Article • The Journal of Urology, May 2024, Wolters Kluwer Health

    Dr Ahmad Ozair

  129. Correction: The role of centre and country factors on process and outcome indicators in critically ill patients with hospital-acquired bloodstream infections

    Article • Intensive Care Medicine, April 2024, Springer Science + Business Media

    Dr Ahmad Ozair

  130. 151 Exceptional Responders to Base Excision Repair (BER) Inhibition for Recurrent Glioblastoma Display Enrichment for DNA Damage Response Pathways: RNA Sequencing Analysis From a Multicenter Trial

    Article • Neurosurgery, April 2024, Wolters Kluwer Health

    Dr Ahmad Ozair

  131. 501 Systemic Immunological Suppression in Glioblastoma Is Targeted by Concurrent VEGF and PD-1 Inhibition in a Dose-Dependent Manner: Cellular Indexing of Transcriptomes and Epitopes by Sequencing (CITE-Seq) From a Randomized Controlled Trial

    Article • Neurosurgery, April 2024, Wolters Kluwer Health

    Dr Ahmad Ozair

  132. Safety and Feasibility of JAK Inhibitor Ruxolitinib in Newly-Diagnosed High-Grade Gliomas (CRUX): Final Trial Report

    Article • Neurosurgery, April 2024, Wolters Kluwer Health

    Dr Ahmad Ozair

  133. MGMT Methylation and Differential Survival Impact by Sex in Glioblastoma

    Article • Cancers, March 2024, MDPI AG

    Dr Ahmad Ozair

  134. The role of centre and country factors on process and outcome indicators in critically ill patients with hospital-acquired bloodstream infections

    Article • Intensive Care Medicine, March 2024, Springer Science + Business Media

    Dr Ahmad Ozair

  135. Disparities in Noninvasive Traditional and Advanced Testing for Coronary Artery Disease: Findings from the INCAPS-COVID 2 Study

    Article • The American Journal of Cardiology, March 2024, Elsevier

    Dr Ahmad Ozair

  136. Outcomes of invasive primary urethral cancer in women: An analysis from the national cancer database

    Article • European Urology, March 2024, Elsevier

    Dr Ahmad Ozair

  137. Treatment strategies and survival outcomes in Non-invasive Primary Urethral Cancer (NPUC): A comprehensive analysis from a large database

    Article • European Urology, March 2024, Elsevier

    Dr Ahmad Ozair

  138. “Open-window” craniectomy for the removal of frontal sinus mucosa to prevent a delayed mucocele: illustrative case

    Article • Journal of Neurosurgery Case Lessons, February 2024, Journal of Neurosurgery Publishing Group (JNSPG)

    Dr Ahmad Ozair

  139. Symptomatic Cerebellar Ptosis following Cerebellar Hematoma Evacuation: A Case Report and Review of the Literature

    Article • Journal of Neurological Surgery Part B Skull Base, February 2024, Thieme Publishing Group

    Dr Ahmad Ozair

  140. Treatment Strategies for Primary Cavernous Sinus Meningiomas: A Systematic Review and Meta-analysis

    Article • Journal of Neurological Surgery Part B Skull Base, February 2024, Thieme Publishing Group

    Dr Ahmad Ozair

  141. Peer Review Report For: Invisibility in global health: A case for disturbing bioethical frameworks [version 2; peer review: 2 approved, 1 approved with reservations]

    Article • February 2024, Faculty of 1000, Ltd.

    Dr Ahmad Ozair

  142. Prophylactic Radiotherapy Of MInimally Symptomatic Spinal Disease (PROMISSeD): study protocol for a randomized controlled trial

    Article • Trials, January 2024, Springer Science + Business Media

    Dr Ahmad Ozair

  143. Financial barriers and inequity in medical education in India: challenges to training a diverse and representative healthcare workforce

    Article • Medical Education Online, January 2024, Taylor & Francis

    Dr Ahmad Ozair

  144. Correction

    Article • Expert Review of Neurotherapeutics, January 2024, Taylor & Francis

    Dr Ahmad Ozair

  145. Impact of tissue-agnostic approvals on management of primary brain tumors

    Article • Trends in Cancer, January 2024, Elsevier

    Dr Ahmad Ozair

  146. An overview of the therapeutic strategies for neoplastic meningitis due to breast cancer: when and why?

    Article • Expert Review of Neurotherapeutics, December 2023, Taylor & Francis

    Dr Ahmad Ozair

  147. Management of Brain Metastases: A Review of Novel Therapies

    Article • Seminars in Neurology, November 2023, Thieme Publishing Group

    Dr Ahmad Ozair

  148. SAGES/AHPBA guidelines for the use of microwave and radiofrequency liver ablation for the surgical treatment of hepatocellular carcinoma or colorectal liver metastases less than 5 cm

    Article • Surgical Endoscopy, November 2023, Springer Science + Business Media

    Dr Ahmad Ozair

  149. Pancreatic surgery outcomes: multicentre prospective snapshot study in 67 countries

    Article • BJS, November 2023, Oxford University Press (OUP)

    Özgül Düzgün , Prof. Dr. Mahmoud ElFiky, Dr Ahmad Ozair, Shoukrie Shoukrie, Dimitrios Magouliotis, Marcos Perini

  150. CTNI-08. TUCATINIB, TRASTUZUMAB, AND CAPECITABINE WITH STEREOTACTIC RADIOSURGERY IN PATIENTS WITH BRAIN METASTASES FROM HER-2 POSITIVE BREAST CANCER (TUTOR): A MULTICENTER PHASE 1 CLINICAL TRIAL

    Article • Neuro-Oncology, November 2023, Oxford University Press (OUP)

    Dr Ahmad Ozair

  151. CTNI-21. PHASE I STUDY OF BTK INHIBITOR IBRUTINIB WITH TEMOZOLOMIDE AND RADIATION IN NEWLY-DIAGNOSED GLIOBLASTOMA (EQUILIBRIUM): FINAL TRIAL REPORT

    Article • Neuro-Oncology, November 2023, Oxford University Press (OUP)

    Dr Ahmad Ozair

  152. CTNI-55. A MULTICENTER STUDY OF LOW-INTENSITY FOCUSED ULTRASOUND WITH SYSTEMIC MICROBUBBLE OSCILLATORS FOR BLOOD-BRAIN BARRIER DISRUPTION FOR LIQUID BIOPSY IN GLIOBLASTOMA (LIBERATE)

    Article • Neuro-Oncology, November 2023, Oxford University Press (OUP)

    Dr Ahmad Ozair

  153. DNAR-05. EXCEPTIONAL RESPONDERS TO BASE EXCISION REPAIR (BER) INHIBITION FOR RECURRENT GLIOBLASTOMA DISPLAY ENRICHMENT FOR DNA DAMAGE RESPONSE PATHWAYS: RNA SEQUENCING ANALYSIS FROM A MULTICENTER TRIAL

    Article • Neuro-Oncology, November 2023, Oxford University Press (OUP)

    Dr Ahmad Ozair

  154. IMMU-02. IS DUAL AGENT IMMUNOTHERAPY SHIFTING THE EPIDEMIOLOGY OF MELANOMA BRAIN METASTASES? A REAL-WORLD ANALYSIS AND SINGLE-INSTITUTION VALIDATION

    Article • Neuro-Oncology, November 2023, Oxford University Press (OUP)

    Dr Ahmad Ozair

  155. IMMU-34. SYSTEMIC IMMUNE SUPPRESSION IN GLIOBLASTOMA IS TARGETED BY CONCURRENT VEGF AND PD-1 INHIBITION IN A DOSE-DEPENDENT MANNER: TRANSCRIPTOMIC FINDINGS THROUGH CITE-SEQ FROM A RANDOMIZED CONTROLLED TRIAL

    Article • Neuro-Oncology, November 2023, Oxford University Press (OUP)

    Dr Ahmad Ozair

  156. RTID-01. A RANDOMIZED STUDY OF LOW-INTENSITY FOCUSED ULTRASOUND FOR BLOOD-BRAIN BARRIER DISRUPTION FOR BRAIN METASTASIS FROM NON-SMALL CELL LUNG CANCER (LIMITLESS)

    Article • Neuro-Oncology, November 2023, Oxford University Press (OUP)

    Dr Ahmad Ozair

  157. SURG-27. 17-YEAR EXPERIENCE OF SURGICAL MANAGEMENT OF INTRADURAL EXTRAMEDULLARY (IDEM) TUMORS: CLINICAL OUTCOMES FROM A LOW- AND MIDDLE-INCOME COUNTRY

    Article • Neuro-Oncology, November 2023, Oxford University Press (OUP)

    Dr Ahmad Ozair

  158. Immune checkpoint inhibition and single fraction stereotactic radiosurgery in brain metastases from non-small cell lung cancer: an international multicenter study of 395 patients

    Article • Journal of Neuro-Oncology, October 2023, Springer Science + Business Media

    Dr Ahmad Ozair

  159. Management of Postoperative Discitis with Debridement and Novel Technique of Local Antibiotic Instillation: Functional Outcomes from a Resource-Limited Setting

    Article • World Neurosurgery, October 2023, Elsevier

    Dr Ahmad Ozair

  160. Cardiovascular Testing in the United States during the COVID-19 Pandemic: Volume Recovery and Worldwide Comparison

    Article • Radiology Cardiothoracic Imaging, October 2023, Radiological Society of North America (RSNA)

    Dr Ahmad Ozair

  161. Endoglin inhibitor TRC105 with or without bevacizumab for bevacizumab-refractory glioblastoma (ENDOT): a multicenter phase II trial

    Article • Communications Medicine, September 2023, Springer Science + Business Media

    Dr Ahmad Ozair

  162. P03.15.B SURGICALLY TARGETED RADIATION THERAPY (START) FOR RECURRENT GLIOBLASTOMA: INITIAL OUTCOMES FROM A PROSPECTIVE MULTICENTER REGISTRY

    Article • Neuro-Oncology, September 2023, Oxford University Press (OUP)

    Dr Ahmad Ozair

  163. P07.09.B A RANDOMIZED PHASE 2B STUDY OF SURVIVIN VACCINE SURVAXM PLUS ADJUVANT TEMOZOLOMIDE FOR NEWLY-DIAGNOSED GLIOBLASTOMA (SURVIVE)

    Article • Neuro-Oncology, September 2023, Oxford University Press (OUP)

    Dr Ahmad Ozair

  164. P07.13.B A RANDOMIZED STUDY OF LOW-INTENSITY FOCUSED ULTRASOUND FOR BLOOD-BRAIN BARRIER DISRUPTION FOR BRAIN METASTASIS FROM NON-SMALL CELL LUNG CANCER (LIMITLESS)

    Article • Neuro-Oncology, September 2023, Oxford University Press (OUP)

    Dr Ahmad Ozair

  165. P14.11.B A MULTICENTER STUDY OF LOW-INTENSITY FOCUSED ULTRASOUND WITH SYSTEMIC MICROBUBBLE OSCILLATORS FOR BLOOD-BRAIN BARRIER DISRUPTION FOR LIQUID BIOPSY IN GLIOBLASTOMA (LIBERATE)

    Article • Neuro-Oncology, September 2023, Oxford University Press (OUP)

    Dr Ahmad Ozair

  166. JS06.5.A TUCATINIB, TRASTUZUMAB, AND CAPECITABINE WITH STEREOTACTIC RADIOSURGERY IN PATIENTS WITH BRAIN METASTASES FROM HER-2 POSITIVE BREAST CANCER (TUTOR): A MULTICENTER PHASE 1 CLINICAL TRIAL

    Article • Neuro-Oncology, September 2023, Oxford University Press (OUP)

    Dr Ahmad Ozair

  167. Neurosurgeon’s Ode to Meningiomas

    Article • Journal of Neurological Surgery Part B Skull Base, July 2023, Thieme Publishing Group

    Dr Ahmad Ozair

  168. Authors' Response to Letter Regarding ‘The US Residency Selection Process After the United States Medical Licensing Examination Step 1 Pass/Fail Change: Overview for Applicants and Educators’ (Preprint)

    Article • June 2023, JMIR Publications Inc.

    Dr Ahmad Ozair

  169. Authors' Reply to: Research Training For Medical Students To Stand Out In Residency Applications. Comment on "The US Residency Selection Process After the United States Medical Licensing Examination Step 1 Pass/Fail Change: Overview for Applicants and ...

    Article • JMIR Medical Education, June 2023, JMIR Publications Inc.

    Dr Ahmad Ozair

  170. Combination of EGFR-Directed Tyrosine Kinase Inhibitors (EGFR-TKI) with Radiotherapy in Brain Metastases from Non-Small Cell Lung Cancer: A 2010–2019 Retrospective Cohort Study

    Article • Cancers, June 2023, MDPI AG

    Dr Ahmad Ozair

  171. Authorship diversity in global evidence synthesis in genitourinary oncology: A 1998-2022 analysis of cochrane reviews.

    Article • Journal of Clinical Oncology, June 2023, American Society of Clinical Oncology (ASCO)

    Dr Ahmad Ozair

  172. Enhancing lung cancer screening through ‘Saved by the Scan’: Lessons from a multipronged public service advertising program.

    Article • Journal of Clinical Oncology, June 2023, American Society of Clinical Oncology (ASCO)

    Dr Ahmad Ozair

  173. Low-intensity focused ultrasound with systemic microbubble oscillators for blood-brain barrier disruption for liquid biopsy in glioblastoma (LIBERATE).

    Article • Journal of Clinical Oncology, June 2023, American Society of Clinical Oncology (ASCO)

    Dr Ahmad Ozair

  174. Phase I study of BTK inhibitor ibrutinib with temozolomide and radiation in newly-diagnosed glioblastoma (EQUILIBRIUM): Final trial report.

    Article • Journal of Clinical Oncology, June 2023, American Society of Clinical Oncology (ASCO)

    Dr Ahmad Ozair

  175. Safety and feasibility of JAK inhibitor ruxolitinib in newly-diagnosed high-grade gliomas (CRUX): Final toxicity report.

    Article • Journal of Clinical Oncology, June 2023, American Society of Clinical Oncology (ASCO)

    Dr Ahmad Ozair

  176. Survival outcomes of micropapillary versus classic variant, loco-regional bladder cancer: A 2004-2019 National Cancer Database analysis.

    Article • Journal of Clinical Oncology, June 2023, American Society of Clinical Oncology (ASCO)

    Dr Ahmad Ozair

  177. Survival outcomes of sarcomatoid versus classic urothelial carcinoma of bladder.

    Article • Journal of Clinical Oncology, June 2023, American Society of Clinical Oncology (ASCO)

    Dr Ahmad Ozair

  178. Ethnic disparities in biomarker testing and targeted therapy use in metastatic lung adenocarcinoma: A 2014-2021 analysis.

    Article • Journal of Clinical Oncology, June 2023, American Society of Clinical Oncology (ASCO)

    Dr Ahmad Ozair

  179. Surgically targeted radiation therapy (STaRT) for recurrent glioblastoma: Initial outcomes from a prospective multicenter registry.

    Article • Journal of Clinical Oncology, June 2023, American Society of Clinical Oncology (ASCO)

    Dr Ahmad Ozair

  180. First- versus Third-Generation EGFR Tyrosine Kinase Inhibitors in EGFR-Mutated Non-Small Cell Lung Cancer Patients with Brain Metastases

    Article • Cancers, April 2023, MDPI AG

    Dr Ahmad Ozair

  181. Reducing the environmental impact of surgery on a global scale: systematic review and co-prioritization with healthcare workers in 132 countries

    Article • BJS, April 2023, Oxford University Press (OUP)

    Prof. Antonio Simone Laganà, Dr. Josep M Muñoz Vives, Muhammad Umar Younis, Dr Ahmad Ozair, Prof. Dr. Mahmoud ElFiky, Dr alberto maria saibene, Alfie J Kavalakat, Prof Marcello Migliore, Professor Gianluca Franceschini, Prof NDUBUISI ONYEMAECHI, Dr Rabea A Gadelkareem, Dimitrios Magouliotis, Justin Wormald, Shoukrie Shoukrie, Dr. Bruno Martinez-Leo, Professor Wim Ceelen, Khaled AL-Sayaghi, Professor Dickon Hayne, Mostafa Shalaby, Roberto Colasanti, Dr. Luca Bertolaccini, Dr. Jessica G.Y. Luc, Pritik A Shah, Dr Vin Shen Ban, Dr Fabio Martinelli, Dr. Musbahu Sani Kurawa, Prof. Dr. Alex Alfieri

  182. Authorship Diversity in Urology: 1998-2022 Cochrane Review Analysis

    Article • BJU International, April 2023, Wiley

    Dr Ahmad Ozair

  183. Diploic Bone Channel Drilling Facilitates Dissection of the Midline Dura and Protects the Superior Sagittal Sinus in Hyperostosis Frontalis Interna

    Article • Cureus, March 2023, Springer Science + Business Media

    Dr Ahmad Ozair

  184. SAGES/AHPBA guidelines for the use of minimally invasive surgery for the surgical treatment of colorectal liver metastases (CRLM)

    Article • Surgical Endoscopy, February 2023, Springer Science + Business Media

    Dr Ahmad Ozair

  185. DNA Methylation and Histone Modification in Low-Grade Gliomas: Current Understanding and Potential Clinical Targets

    Article • Cancers, February 2023, MDPI AG

    Dr Ahmad Ozair

  186. Who coauthors Cochrane Reviews related to genitourinary cancers? A 1998-2022 analysis of country and gender diversity.

    Article • Journal of Clinical Oncology, February 2023, American Society of Clinical Oncology (ASCO)

    Dr Ahmad Ozair

  187. Epidemiology and outcomes of hospital-acquired bloodstream infections in intensive care unit patients: the EUROBACT-2 international cohort study

    Article • Intensive Care Medicine, February 2023, Springer Science + Business Media

    Dr Ahmad Ozair, Dr Ashraf Essam Roshdy, Shraddha Goyal

  188. Treatments for intracranial hypertension in acute brain-injured patients: grading, timing, and association with outcome. Data from the SYNAPSE-ICU study

    Article • Intensive Care Medicine, January 2023, Springer Science + Business Media

    Dr Ahmad Ozair

  189. The US Residency Selection Process After the United States Medical Licensing Examination Step 1 Pass/Fail Change: Overview for Applicants and Educators

    Article • JMIR Medical Education, January 2023, JMIR Publications Inc.

    Dr Ahmad Ozair

  190. Monitoring committees in clinical trials

    Article • January 2023, Elsevier

    Dr Ahmad Ozair

  191. Phases of clinical trials

    Article • January 2023, Elsevier

    Dr Ahmad Ozair

  192. Correlation

    Article • January 2023, Elsevier

    Dr Ahmad Ozair

  193. List of contributors

    Article • January 2023, Elsevier

    Dr Ahmad Ozair

  194. Serum Thyroid-Stimulating Hormone and 25-Hydroxycholecalciferol Levels in Children with Autism Spectrum Disorder and Intellectual Disability in Northern India: A Case-Control Study

    Article • December 2022, Cold Spring Harbor Laboratory Press

    Dr Ahmad Ozair

  195. Novel Therapeutic Approaches in Neoplastic Meningitis

    Article • Cancers, December 2022, MDPI AG

    Dr Ahmad Ozair

  196. Surgical approach to microwave and radiofrequency liver ablation for hepatocellular carcinoma and colorectal liver metastases less than 5 cm: a systematic review and meta-analysis

    Article • Surgical Endoscopy, December 2022, Springer Science + Business Media

    Dr Ahmad Ozair

  197. Inequities in Country- and Gender-Based Authorship Representation in Cardiology-Related Cochrane Reviews

    Article • JACC Advances, December 2022, Elsevier

    Dr Ahmad Ozair, MD Monil Majmundar

  198. Serum Thyroid-Stimulating Hormone and 25-Hydroxycholecalciferol Levels in Children with Autism Spectrum Disorder and Intellectual Disability in Northern India: A Case-Control Study (Preprint)

    Article • November 2022, JMIR Publications Inc.

    Dr Ahmad Ozair

  199. The Future of Pulmonary Medicine Physician Work-Force in India

    Article • The Indian Journal of Chest Diseases and Allied Sciences, November 2022, Jaypee Brothers Medical Publishing

    Dr Ahmad Ozair

  200. Elective surgery system strengthening: development, measurement, and validation of the surgical preparedness index across 1632 hospitals in 119 countries

    Article • The Lancet, November 2022, Elsevier

    Prof. Antonio Simone Laganà, Muhammad Umar Younis, Dr. Josep M Muñoz Vives, Dr Ahmad Ozair, Dr. Mahmoud A. Ebada, Dr Mohmmad Khursheed Alam, Dr Katerina Kasapinova, Dr alberto maria saibene, Alfie J Kavalakat, funlayo odejinmi, Prof Marcello Migliore, Professor Gianluca Franceschini, Prof NDUBUISI ONYEMAECHI, Francesco Di Marzo, Dr Rabea A Gadelkareem, Professor Calvin S.H. Ng, Prof. Dr. Mahmoud ElFiky, Dimitrios Magouliotis, Professor Badr Eldin Mostafa, Prof Marco Clementi, Dale Vimalachandran, Dr Tjokorda Gde Agung Senapathi, Dr khaled Mohamed Abdel wahab , Gerardo Caruso, Hitesh Chopra, Mostafa Shalaby, Roberto Colasanti, Dr. Luca Bertolaccini, Prof. Shadi Hamouri, Dr. Jessica G.Y. Luc, Dr Vin Shen Ban, Dr Fabio Martinelli, Dr. Musbahu Sani Kurawa, Dr Fakher Rahim

  201. Twelve-month observational study of children with cancer in 41 countries during the COVID-19 pandemic

    Article • BMJ Global Health, October 2022, BMJ

    Dr Ahmad Ozair, Dr. Mahmoud A. Ebada, Prof. Dr. Mahmoud ElFiky, Professor Dr. Ashrarur Rahman Mitul, Dr Fakher Rahim

  202. Minimally invasive versus open hepatectomy for the resection of colorectal liver metastases: a systematic review and meta-analysis

    Article • Surgical Endoscopy, September 2022, Springer Science + Business Media

    Dr Ahmad Ozair

  203. COVID-19-Associated Mucormycosis in a Tertiary Care Hospital in India: A Case Series

    Article • Cureus, August 2022, Cureus, Inc.

    Dr Ahmad Ozair

  204. Intracranial Pressure Monitoring in Patients With Spontaneous Intracerebral Hemorrhage

    Article • Neurology, May 2022, Wolters Kluwer Health

    Dr Ahmad Ozair

  205. Authorship Diversity in Cochrane Systematic Reviews of Stroke: Inequities in Global Representation (P18-2.002)

    Article • Neurology, May 2022, Wolters Kluwer Health

    Dr Ahmad Ozair

  206. Worldwide Disparities in Recovery of Cardiac Testing 1 Year Into COVID-19

    Article • Journal of the American College of Cardiology, May 2022, Elsevier

    Dr Ahmad Ozair, Professor marija B Vavlukis, Associate Professor Dr Noor Khairiah A. Karim

  207. Rising Inequity and Disparities in Medical Education in India: Challenges to Training a Representative Workforce (Preprint)

    Article • April 2022, JMIR Publications Inc.

    Dr Ahmad Ozair

  208. Advanced subspecialty cardiology training in India in 2022: challenges and future directions

    Article • European Heart Journal, March 2022, Oxford University Press (OUP)

    Dr Ahmad Ozair

  209. Casemix, management, and mortality of patients receiving emergency neurosurgery for traumatic brain injury in the Global Neurotrauma Outcomes Study: a prospective observational cohort study

    Article • The Lancet Neurology, March 2022, Elsevier

    Dr Ahmad Ozair, Dr. Nebojsa Lasica, Dr Marwa SaedAli Emhemed, Dr Vin Shen Ban

  210. COUNTRY AND GENDER DIVERSITY IN CARDIOLOGY-RELATED COCHRANE REVIEWS: INEQUITIES IN GLOBAL REPRESENTATION

    Article • Journal of the American College of Cardiology, March 2022, Elsevier

    Dr Ahmad Ozair

  211. Total hip arthroplasty for failed osteosynthesis of proximal femoral fractures: Clinical outcomes from a low- and middle-income country

    Article • Journal of Arthroscopy and Joint Surgery, January 2022, Medknow

    Dr Ahmad Ozair

  212. Overseas Medical Students in Ukraine and War-Related Interruption in Education: Global Health Considerations from India

    Article • Annals of Global Health, January 2022, Ubiquity Press, Ltd.

    Dr Ahmad Ozair

  213. Management of postoperative discitis with debridement and local antibiotic infusion: functional outcomes from a low-middle-income country

    Article • Brain and Spine, January 2022, Elsevier

    Dr Ahmad Ozair

  214. Functional outcomes after modified Blair's procedure for ankle arthritis secondary to Hawkins type III talus injuries: A retrospective cohort study

    Article • Journal of Arthroscopy and Joint Surgery, January 2022, Medknow

    Dr Ahmad Ozair

  215. In Reply: Predictors of Academic Neurosurgical Career Trajectory Among International Medical Graduates Training Within the United States

    Article • Neurosurgery, December 2021, Wolters Kluwer Health

    Dr Ahmad Ozair

  216. The perceived impact of the Covid-19 pandemic on medical student education and training – an international survey

    Article • BMC Medical Education, November 2021, Springer Science + Business Media

    Dr Ahmad Ozair

  217. 2021 Scientific Session of the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES), Las Vegas, Nevada, 31 August–3 September 2021: Posters

    Article • Surgical Endoscopy, November 2021, Springer Science + Business Media

    Dr Ahmad Ozair

  218. Educating the Next Generation of Global Neurosurgeons: Competencies, Skills, and Resources for Medical Students Interested in Global Neurosurgery

    Article • World Neurosurgery, November 2021, Elsevier

    Dr Ahmad Ozair

  219. Percutaneous image-guided cryoablation of spinal metastases: A systematic review

    Article • Journal of Clinical Neuroscience, November 2021, Elsevier

    Dr Ahmad Ozair

  220. Pediatric Brain Tumors: From Modern Classification System to Current Principles of Management

    Article • October 2021, IntechOpen

    Dr Ahmad Ozair

  221. BJS commission on surgery and perioperative care post-COVID-19

    Article • BJS, October 2021, Oxford University Press (OUP)

    Muhammad Umar Younis, Francesco Di Marzo, Dr Ahmad Ozair, Vittoria Bellato, Dr DARYLL M BAKER, Mostafa Shalaby

  222. Comparison of Blister Aneurysm Treatment Techniques: A Systematic Review and Meta-Analysis

    Article • World Neurosurgery, October 2021, Elsevier

    Dr Ahmad Ozair

  223. Impact of COVID-19 on Diagnostic Cardiac Procedural Volume in Oceania: The IAEA Non-Invasive Cardiology Protocol Survey on COVID-19 (INCAPS COVID)

    Article • Heart Lung and Circulation, October 2021, Elsevier

    Dr Ahmad Ozair

  224. Learning to practice medicine during COVID-19 and mucormycosis epidemics: an intern perspective from India

    Article • IJS Short Reports, October 2021, Wolters Kluwer Health

    Dr Ahmad Ozair

  225. Reduction of cardiac imaging tests during the COVID-19 pandemic: The case of Italy. Findings from the IAEA Non-invasive Cardiology Protocol Survey on COVID-19 (INCAPS COVID)

    Article • International Journal of Cardiology, October 2021, Elsevier

    Dr Ahmad Ozair

  226. Impact of COVID-19 on Cardiovascular Testing in the United States Versus the Rest of the World

    Article • JACC Cardiovascular Imaging, September 2021, Elsevier

    Dr Nobuo Tomizawa, Dr Ahmad Ozair, Professor marija B Vavlukis, Associate Professor Dr Noor Khairiah A. Karim

  227. Lessons from the life of Asia’s first female neurosurgeon for modern neurosurgical trainees and educators worldwide

    Article • Journal of Neurosurgery, September 2021, Journal of Neurosurgery Publishing Group (JNSPG)

    Dr Ahmad Ozair

  228. MP67-14 SCIENTIFIC AUTHORSHIP OF COCHRANE SYSTEMATIC REVIEWS IN UROLOGY: A 2020 ANALYSIS

    Article • The Journal of Urology, September 2021, Wolters Kluwer Health

    Dr Ahmad Ozair

  229. Impact of COVID-19 Pandemic on Cardiovascular Testing in Asia

    Article • JACC Asia, September 2021, Elsevier

    Dr Ahmad Ozair, Professor marija B Vavlukis, Associate Professor Dr Noor Khairiah A. Karim

  230. State of Accredited Endovascular Neurosurgery Training in India in 2021: Challenges to Capacity Building in Subspecialty Neurosurgical Care

    Article • Frontiers in Surgery, August 2021, Frontiers

    Dr Ahmad Ozair

  231. The Perceived Impact of the Covid-19 Pandemic on Medical Student Education and Training – An International Survey

    Article • August 2021, Research Square

    Dr Ahmad Ozair

  232. SARS‐CoV‐2 infection and venous thromboembolism after surgery: an international prospective cohort study

    Article • Anaesthesia, August 2021, Wiley

    Dr. Mahmoud A. Ebada, Francesco Di Marzo, Dr Ahmad Ozair, Justin Wormald, Dimitrios Magouliotis, Ronald Flumignan, Dr. Musbahu Sani Kurawa, Dr. Josep M Muñoz Vives, Professor Dr. Ashrarur Rahman Mitul, Vittoria Bellato, Dr Shameel Musthafa, MD Aleksandar Bogdanovic, Assia HAIF, Alfie J Kavalakat, Prof Marcello Migliore, Joshua Totty, Martin Karamanliev, Professor Gianluca Franceschini, Prof NDUBUISI ONYEMAECHI, Dr Rabea A Gadelkareem, Professor Calvin S.H. Ng, Professor Dr Osama Farouk, Prof. Dr. Mahmoud ElFiky, Marcos Perini, Aloy Okechukwu Ugwu, Professor Dickon Hayne, Dr Ramesh P Menon, Prof. Dr. Alex Alfieri, Edward Caruana, avinash aujayeb, Roberto Colasanti, Dr. Luca Bertolaccini, Dr Ayrat R. Kaldarov , Dr Vin Shen Ban, Dr Fabio Martinelli

  233. Letter: Predictors of Academic Neurosurgical Career Trajectory Among International Medical Graduates Training Within the United States

    Article • Neurosurgery, August 2021, Oxford University Press (OUP)

    Dr Ahmad Ozair

  234. Effects of pre‐operative isolation on postoperative pulmonary complications after elective surgery: an international prospective cohort study

    Article • Anaesthesia, August 2021, Wiley

    Dr. Mahmoud A. Ebada, Francesco Di Marzo, Dr Ahmad Ozair, Justin Wormald, Dimitrios Magouliotis, Fernando Cordera, Ronald Flumignan, Dr. Musbahu Sani Kurawa, Vittoria Bellato, Dr Shameel Musthafa, MD Aleksandar Bogdanovic, Assia HAIF, Alfie J Kavalakat, funlayo odejinmi, Ademola Adeyeye , Joshua Totty, Professor Gianluca Franceschini, Prof NDUBUISI ONYEMAECHI, Dr Rabea A Gadelkareem, Professor Calvin S.H. Ng, Prof. Saleh S. Baeesa, Professor Dr Osama Farouk, Dr. Josep M Muñoz Vives, Prof. Dr. Mahmoud ElFiky, Marcos Perini, Professor Dickon Hayne, Professor Dr. Ashrarur Rahman Mitul, Prof. Dr. Alex Alfieri, Edward Caruana, avinash aujayeb, Roberto Colasanti, Dr. Luca Bertolaccini, Dr Vin Shen Ban, Dr Fabio Martinelli, Prof Marcello Migliore

  235. Impact of COVID-19 on the imaging diagnosis of cardiac disease in Europe

    Article • Open Heart, August 2021, BMJ

    Dr Ahmad Ozair, Professor marija B Vavlukis, Associate Professor Dr Noor Khairiah A. Karim

  236. Letter: Is the Stupp Protocol an Expensive and Unsustainable Standard of Care for Glioblastoma in Low- and Middle-Income Country Settings? A Call to Action!

    Article • Neurosurgery, July 2021, Oxford University Press (OUP)

    Dr Ahmad Ozair

  237. Anxiety, Uncertainty, and Resilience of Medical Students Worldwide during the COVID-19 Pandemic

    Article • July 2021, IntechOpen

    Dr Ahmad Ozair

  238. Timing of surgery following SARS‐CoV‐2 infection: an international prospective cohort study

    Article • Anaesthesia, July 2021, Wiley

    Dr Ahmad Ozair

  239. Abstract 831: State of medical and surgical oncology training in India: An infrastructural challenge to delivering high-quality cancer care

    Article • July 2021, American Association for Cancer Research (AACR)

    Dr Ahmad Ozair

  240. Intracranial pressure monitoring in patients with acute brain injury in the intensive care unit (SYNAPSE-ICU): an international, prospective observational cohort study

    Article • The Lancet Neurology, July 2021, Elsevier

    Dr Ahmad Ozair

  241. Global Landscape of Glioblastoma Multiforme Management in the Stupp Protocol Era: Systematic Review Protocol

    Article • International Journal of Surgery Protocols, June 2021, IJS Press

    Dr Ahmad Ozair

  242. Letter to the Editor Regarding “Characterizing the Effect of Pass/Fail U.S. Medical Licensing Examination Step 1 Scoring in Neurosurgery: Program Directors' Perspectives”

    Article • World Neurosurgery, June 2021, Elsevier

    Dr Ahmad Ozair

  243. The perceived global impact of the COVID‐19 pandemic on doctors’ medical and surgical training: An international survey

    Article • International Journal of Clinical Practice, May 2021, Hindawi Publishing Corporation

    Dr Ahmad Ozair

  244. Antibiotics for treatment of irritable bowel syndrome in adults

    Article • Cochrane Database of Systematic Reviews, May 2021, Wiley

    Dr Ahmad Ozair

  245. Medical Students in Global Neurosurgery: Rationale and Role

    Article • JOURNAL OF GLOBAL NEUROSURGERY, April 2021, Meditech Foundation

    Dr Ahmad Ozair

  246. Retractions and Withdrawals in Neurology Literature: A 2020 Analysis of the Retraction Watch Database (2668)

    Article • Neurology, April 2021, Wolters Kluwer Health

    Dr Ahmad Ozair

  247. The perceived global impact of the COVID-19 pandemic on doctors’ medical and surgical training: an international survey

    Article • March 2021, Authorea, Inc.

    Dr Ahmad Ozair

  248. SARS-CoV-2 vaccination modelling for safe surgery to save lives: data from an international prospective cohort study

    Article • BJS, March 2021, Oxford University Press (OUP)

    Professor Badr Eldin Mostafa, Dr. Mahmoud A. Ebada, Dimitrios Magouliotis, Professor Dr. Ashrarur Rahman Mitul, Roberto Colasanti, Justin Wormald, Dr. Josep M Muñoz Vives, Francesco Di Marzo, Dr Ahmad Ozair, Ronald Flumignan, Vittoria Bellato, Dr Shameel Musthafa, Dr kehinde sharafadeen okunade, MD Aleksandar Bogdanovic, Assia HAIF, Alfie J Kavalakat, funlayo odejinmi, Joshua Totty, Professor Gianluca Franceschini, Prof NDUBUISI ONYEMAECHI, Dr Rabea A Gadelkareem, Professor Calvin S.H. Ng, Prof. Saleh S. Baeesa, Ahmad Ramzi Yusoff, Professor Dr Osama Farouk, Prof. Dr. Mahmoud ElFiky, Marcos Perini, Emre Balık, Prof. Dr. Alex Alfieri, Edward Caruana, Dr. Luca Bertolaccini, Dr Ayrat R. Kaldarov , Dr Vin Shen Ban, Dr Fabio Martinelli, Dr. Musbahu Sani Kurawa, Professor Khaled Saad

  249. Timing of surgery following SARS-CoV-2 infection

    Article • Anaesthesia, March 2021, Wiley

    Dr. Mahmoud A. Ebada, Professor Badr Eldin Mostafa, Professor shahnoor islam, Professor Dr. Ashrarur Rahman Mitul, Dimitrios Magouliotis, Roberto Colasanti, Justin Wormald, Dr. Josep M Muñoz Vives, Francesco Di Marzo, Dr Ahmad Ozair, Stênio Zequi, Ronald Flumignan, Dr. Musbahu Sani Kurawa, Vittoria Bellato, Dr Shameel Musthafa, Dr kehinde sharafadeen okunade, MD Aleksandar Bogdanovic, Assia HAIF, Alfie J Kavalakat, Ademola Adeyeye , Joshua Totty, Professor Gianluca Franceschini, Prof NDUBUISI ONYEMAECHI, Dr Rabea A Gadelkareem, Professor Calvin S.H. Ng, Prof. Saleh S. Baeesa, Ahmad Ramzi Yusoff, Professor Dr Osama Farouk, Prof. Dr. Mahmoud ElFiky, Marcos Perini, Professor Dickon Hayne, Dr Ramesh P Menon, Prof. Dr. Alex Alfieri, Edward Caruana, avinash aujayeb, Dr. Luca Bertolaccini, Fernando Cordera, Dr Vin Shen Ban, Dr Fabio Martinelli, Prof Marcello Migliore

  250. Biographies of international women leaders in neurosurgery

    Article • Neurosurgical FOCUS, March 2021, Journal of Neurosurgery Publishing Group (JNSPG)

    Dr Ahmad Ozair

  251. Decline of Empathy During Medical Education

    Article • Academic Medicine, February 2021, Wolters Kluwer Health

    Dr Ahmad Ozair

  252. Decline of Empathy During Medical Education

    Article • Academic Medicine, February 2021, Wolters Kluwer Health

    Dr Ahmad Ozair

  253. Delivering High-Quality, Equitable Care in India: An Ethically-Resilient Framework for Healthcare Innovation After COVID-19

    Article • Frontiers in Public Health, February 2021, Frontiers

    Dr Ahmad Ozair

  254. Letter by Ozair et al Regarding Article, “The Upcoming Epidemic of Heart Failure in South Asia”

    Article • Circulation Heart Failure, February 2021, Wolters Kluwer Health

    Dr Ahmad Ozair

  255. International Impact of COVID-19 on the Diagnosis of Heart Disease

    Article • Journal of the American College of Cardiology, January 2021, Elsevier

    Dr Ahmad Ozair, Professor marija B Vavlukis, Associate Professor Dr Noor Khairiah A. Karim

  256. SARS-CoV-2 Vaccination in India: Considerations of Hesitancy and Bioethics in Global Health

    Article • Annals of Global Health, January 2021, Ubiquity Press, Ltd.

    Dr Ahmad Ozair

  257. Large Cerebral Infarction in Tuberculous Meningitis: Case Report of an Uncommon Complication

    Article • Neurology India, January 2021, Medknow

    Dr Ahmad Ozair

  258. Scrub Typhus Presenting with Hemiparesis: Case Report of a Rare Manifestation

    Article • Neurology India, January 2021, Medknow

    Dr Ahmad Ozair

  259. 0.54111/0001/vv16

    Article • January 2021, Boston Congress of Public Health

    Dr Ahmad Ozair

  260. Adherence to Lockdown and Social-Distancing Policies Amidst COVID-19 Pandemic: A Behavioral and Socio-Economic Perspective from India

    Article • January 2021, Boston Congress of Public Health

    Dr Ahmad Ozair

  261. Letter to the Editor Regarding “Strategies to Address Projected Challenges Facing Foreign Applicants in the U.S. Neurosurgery Match”

    Article • World Neurosurgery, December 2020, Elsevier

    Dr Ahmad Ozair

  262. ACUTE FATTY LIVER OF PREGNANCY PRESENTING AS INTRAUTERINE FETAL DEATH, POSTPARTUM HEMORRHAGE AND MULTI-ORGAN FAILURE: NEED FOR A MULTI-DISCIPLINARY, INTENSIVIST-LED MANAGEMENT

    Article • CHEST Journal, October 2020, Elsevier

    Dr Ahmad Ozair

  263. Learning high‐value care in developing countries

    Article • The Clinical Teacher, September 2020, Wiley

    Dr Ahmad Ozair

  264. Why are India’s Best Medical Graduates not Preferring ENT for Postgraduate Training Through NEET-PG?

    Article • Indian Journal of Otolaryngology and Head & Neck Surgery, June 2020, Springer Science + Business Media

    Dr Ahmad Ozair

  265. Abstracts from the International Science Symposium on HIV and Infectious Diseases (ISSHID 2019): Infectious diseases

    Article • BMC Infectious Diseases, May 2020, Springer Science + Business Media

    Ms. Leila Fotooh Abadi, Dr Ahmad Ozair

  266. Scrub Typhus: Case of a Rare Etiology Behind Intracerebral Hemorrhage (204)

    Article • Neurology, April 2020, Wolters Kluwer Health

    Dr Ahmad Ozair

  267. Stroke in persons with disability

    Article • Neurology, January 2020, Wolters Kluwer Health

    Dr Ahmad Ozair, Mr Ahmad Ozair

  268. Postoperative urinary retention: A controlled trial of fixed-dose spinal anesthesia using bupivacaine versus ropivacaine

    Article • Journal of Anaesthesiology Clinical Pharmacology, January 2020, Medknow

    Dr Ahmad Ozair

  269. Transhepatic intraperitoneally migrated biliary stent: A rare finding during laparoscopic cholecystectomy

    Article • Journal of Minimal Access Surgery, January 2020, Medknow

    Dr Ahmad Ozair

  270. Training and Delivery of Critical Care Medicine in India: Concerns Revealed by COVID-19 Pandemic

    Article • Indian Journal of Critical Care Medicine, January 2020, Jaypee Brothers Medical Publishing

    Dr Ahmad Ozair

  271. A rare etiology behind isolated lateral rectus palsy: Scrub typhus

    Article • Journal of Family Medicine and Primary Care, January 2020, Medknow

    Dr Ahmad Ozair

  272. Scrub typhus manifesting with intracerebral hemorrhage: Case report and review of literature

    Article • Journal of Family Medicine and Primary Care, January 2020, Medknow

    Dr Ahmad Ozair

  273. Impaled roadside guardrail in the neck: Case of a failed motorcycle stunt

    Article • Journal of Family Medicine and Primary Care, January 2020, Medknow

    Dr Ahmad Ozair

  274. Academic quality of incoming ophthalmology residents in India: Concerns for the future

    Article • Indian Journal of Ophthalmology, January 2020, Medknow

    Dr Ahmad Ozair

  275. Bilateral limb gangrene in an HIV patient due to vasculopathy: Managing the dual challenge of psychosocial issues and an uncommon medical condition

    Article • Journal of Family Medicine and Primary Care, January 2020, Medknow

    Dr Ahmad Ozair

  276. Upsurge of chikungunya cases in Uttar Pradesh, India

    Article • International Journal of Microbiology Research, January 2020, Medknow

    Dr Ahmad Ozair

  277. The US Residency Selection Process After the United States Medical Licensing Examination Step 1 Pass/Fail Change: Overview for Applicants and Educators

    Article • Rescognito, Inc.

    Dr Ahmad Ozair

  278. The US Residency Selection Process After the United States Medical Licensing Examination Step 1 Pass/Fail Change: Overview for Applicants and Educators

    Article • Rescognito, Inc.

    Dr Ahmad Ozair